Proteome Sciences' H1 2012 Revenues Improve 44 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Proteome Sciences today said that revenues during the first half of 2012 rose 44 percent year over year.

For the period ended June 30, the Cobham, UK-based firm posted £892,827 ($1.4 million) in revenues, up from £618,982 for the first half of 2011. Grant services grew 53 percent year over year, Licenses/Sales/Services increased 38 percent, and TMT reagent sales rose 171 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.